Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Molecular Informatics
|
July 28, 2016
Missing Value Estimation for Compound-Target Activity Data
Yusuf Tanrikulu, Rama Kondru, Gisbert Schneider, et al.
Journal of Chemical Information and Modeling
|
May 16, 2012
PROLIX: rapid mining of protein-ligand interactions in large crystal structure databases
Martin Weisel, Hans-Marcus Bitter, François Diederich, et al.
Molecular Pharmacology
|
December 22, 2007
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists
Rama Kondru, Jun Zhang, Changhua Ji, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 13, 2019
A potent seven-membered cyclic BTK (Bruton's tyrosine Kinase) chiral inhibitor conceived by structure-based drug design to lock its bioactive conformation
Francisco Lopez-Tapia, Yan Lou, Christine Brotherton-Pleiss, et al.
Molecular Informatics
|
August 3, 2016
A Crowd-Based Process and Tool for HTS Hit Triage
Zhengwei Peng, Paul Gillespie, Martin Weisel, et al.
Chemical Biology & Drug Design
|
February 18, 2009
Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes
Armando G Villaseñor, Rama Kondru, Hoangdung Ho, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 3, 2010
Modeling bone marrow toxicity using kinase structural motifs and the inhibition profiles of small molecular kinase inhibitors
Andrew J Olaharski, Hans Bitter, Nina Gonzaludo, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2007
The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies
Jun Zhang, Eileen Rao, Marianna Dioszegi, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 22, 2010
Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series
Jutta Wanner, Lijing Chen, Rémy C Lemoine, et al.
British Journal of Pharmacology
|
March 18, 2014
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands
David C Swinney, Paul Beavis, Kai-Ting Chuang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Molecular Informatics
|
July 28, 2016
Missing Value Estimation for Compound-Target Activity Data
Yusuf Tanrikulu, Rama Kondru, Gisbert Schneider, et al.
Journal of Chemical Information and Modeling
|
May 16, 2012
PROLIX: rapid mining of protein-ligand interactions in large crystal structure databases
Martin Weisel, Hans-Marcus Bitter, François Diederich, et al.
Molecular Pharmacology
|
December 22, 2007
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists
Rama Kondru, Jun Zhang, Changhua Ji, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 13, 2019
A potent seven-membered cyclic BTK (Bruton's tyrosine Kinase) chiral inhibitor conceived by structure-based drug design to lock its bioactive conformation
Francisco Lopez-Tapia, Yan Lou, Christine Brotherton-Pleiss, et al.
Molecular Informatics
|
August 3, 2016
A Crowd-Based Process and Tool for HTS Hit Triage
Zhengwei Peng, Paul Gillespie, Martin Weisel, et al.
Chemical Biology & Drug Design
|
February 18, 2009
Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes
Armando G Villaseñor, Rama Kondru, Hoangdung Ho, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 3, 2010
Modeling bone marrow toxicity using kinase structural motifs and the inhibition profiles of small molecular kinase inhibitors
Andrew J Olaharski, Hans Bitter, Nina Gonzaludo, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2007
The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies
Jun Zhang, Eileen Rao, Marianna Dioszegi, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 22, 2010
Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series
Jutta Wanner, Lijing Chen, Rémy C Lemoine, et al.
British Journal of Pharmacology
|
March 18, 2014
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands
David C Swinney, Paul Beavis, Kai-Ting Chuang, et al.
Page
of 2